Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietar...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Polyrizon adopts new executive, director pay policy with bonus, equity caps
Polyrizon flags release on NASARIX biocompatibility program results
Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial | PLRZ Stock News
Polyrizon wins central IRB clearance to start first NASARIX allergy blocker human trial
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial | PLRZ Stock News